IRCT20130603013572N5招募中未知
Bioequivalence Evaluation of Losartan and Cozaar® formulations in healthy volunteers
Daana pharma.Co0 个研究点目标入组 26 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 26
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- All
入选标准
- •in healthy male and female volunteers
排除标准
- •History of hypersensitivity to the study drug or related products.
- •Significant history or presence of gastrointestinal, kidney disease or any otherconditions known to interfere with the absorption, distribution, metabolism orexcretion of common medications.
- •Significant history of asthma, chronic bronchitis or other bronchospasticcondition.
- •Significant history or presence of glaucoma, cardiovascular or hematologicaldisease.
- •Any clinically significant illness during the 4 weeks prior to day of this study.
- •Maintenance therapy with any drug, or history of drug dependency, alcoholabuse, or serious neurological or psychological disease.
- •Participation in a clinical trial with an investigation drug within 30 dayspreceding day 1 of this study.
- •Use of enzyme- modifying drugs within 30 days prior to day 1 of this study.
- •Use of any systemic medication (including OTC preparations) within 14 daysprior day 1 of this study.
- •HIV and Hepatitis B and anti HCV antibody positive subjects.
- •History of difficulty in donating blood
- •Donation of blood within 90 days before first dosing.
- •History of vaccination within one month before first dosing.
研究者
相似试验
已完成
不适用
A bioequivalence study of losartan H 50/12.5 mg tablet compared to Hyzaar 50/12.5 mg tablet manufactured by Merck in 24 healthy volunteers under fasting conditioBlood concentration of test and reference drug is compared.IRCT20220209053979N2Alborz Darou24
已完成
不适用
Comparison of two treatment regimens in reduction of proteinuria in diabetic patientsDiabetic nephropathy.Glomerular disorders in diabetes mellitusN08.3*IRCT2012121311743N1Tabriz University of Medical Sciences44
招募中
不适用
Investigating the in vivo bioequivalence of losartan 50 mgIn the present study, the products will be administered to healthy volunteers..IRCT20220211053992N4Tabriz University of Medical Sciences24
尚未招募
不适用
Investigating the in vivo bioequivalence of losartan 50 mgIRCT20210519051345N23Tabriz University of Medical Sciences24
已完成
1 期
Bioequivalence of Losartan and Hydrochlorothiazide (HCTZ) Combination Tablet and Coadministration of Its Components (0954A-306)HypertensionNCT00953680Organon and Co77